Categories
CoronaVirus News

Sen-Jam Pharmaceutical Completes Enrollment for Phase 2 Upper Respiratory Infection/COVID Therapeutic – PR Newswire


Sen-Jam Pharmaceutical Completes Enrollment for Phase 2 Upper Respiratory Infection/COVID Therapeutic  PR Newswire